{"id":45784,"date":"2019-10-08T09:00:02","date_gmt":"2019-10-08T13:00:02","guid":{"rendered":"https:\/\/wfh.org\/recommandation-de-la-fmh-sur-la-presence-de-matiere-particulaire-dans-lemicizumab-hemlibra-et-dautres-agents-biologiques\/"},"modified":"2024-04-22T14:40:20","modified_gmt":"2024-04-22T18:40:20","slug":"recommandation-de-la-fmh-sur-la-presence-de-matiere-particulaire-dans-lemicizumab-hemlibra-et-dautres-agents-biologiques","status":"publish","type":"post","link":"https:\/\/wfh.org\/fr\/article\/recommandation-de-la-fmh-sur-la-presence-de-matiere-particulaire-dans-lemicizumab-hemlibra-et-dautres-agents-biologiques\/","title":{"rendered":"Recommandation de la FMH sur la pr\u00e9sence de mati\u00e8re particulaire dans l\u2019emicizumab (HEMLIBRA) et d\u2019autres agents biologiques"},"content":{"rendered":"\t\t